Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | MPO | P05164 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 3/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | ECE1 | P42892 | 4/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29828489 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828590 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828735 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828711 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828379 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828273 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828570 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29829559 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL30096995 | 1.00 | KDM4E (0.59) | KDM4EMEN1LMNAMPOMAPT | |
| SCHEMBL29828574 | 0.96 | KDM4E (0.64) | KDM4EMEN1LMNAMPOMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051326-A1 | Antiinfective Lipopeptides | CUBIST PHARMACEUTICALS, INC. | 2008-02-28 | — | — | US | disclosed |
| US-20080051326-A1 | Antiinfective Lipopeptides | CUBIST PHARMACEUTICALS, INC. | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051326-A1 | Antiinfective Lipopeptides | VIP, NGLY1, PREP | KDM4E 3848/4885MEN1 2623/4885LMNA 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.